Faster-acting drugs have long been sought to protect people with severe depression who may be at risk of self-harm or suicide ...
Regenerative Medicine Advanced Therapy (RMAT) designation follows Phase Ib 36-month data Study demonstrated favorable safety profile and continued positive trends in assessed clinical outcome measures ...
Data reinforce dose-dependent mechanism with IMNN-001 100mg/m 2 dose associated with 20% increase in IL-12 levels compared to 79mg/m 2 dose. Results from OVATION 2 Study continue ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback